prednisolone has been researched along with Brittle Bone Disease in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhadada, SK | 1 |
| Dhaliwal, R | 1 |
| Dhiman, V | 1 |
| Rao, SD | 1 |
| Naiki, Y | 1 |
| Tanaka, T | 1 |
2 reviews available for prednisolone and Brittle Bone Disease
| Article | Year |
|---|---|
Fibrogenesis Imperfecta Ossium.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Collagen; Diphosphonates; Di | 2019 |
[Osteoporosis caused by pediatric diseases].
Topics: Anorexia Nervosa; Bone Density; Calcium; Child; Diphosphonates; Gonadotropin-Releasing Hormone; Huma | 2005 |